GlaxoSmithkline Consumer Healthcare jumps after good Q3 results

GlaxoSmithkline Consumer Healthcare rose 7.44% to Rs 6,425 at 12:20 IST on BSE after net profit rose 19.98% to Rs 163.66 crore on 20.26% rise in net sales to Rs 1034.67 crore in Q3 December 2017 over Q3 December 2016.

The results were announced after market hours on Monday, 12 February 2018. The domestic stock market was shut yesterday, 13 February 2018, on account of Mahashivratri.

Meanwhile, the S&P BSE Sensex was down 13.84 points, or 0.04% to 34,286.63.

On the BSE, 62,000 shares were traded in the counter so far compared with average daily volumes of 6,075 shares in the past one quarter. The stock had hit a high of Rs 6,490 and a low of Rs 6,059 so far during the day. The stock hit a 52-week high of Rs 6,798.85 on 31 January 2018. The stock hit a 52-week low of Rs 4,856.05 on 29 September 2017.

The stock had underperformed the market over the past 30 days till 12 February 2018, falling 7.68% compared with 0.84% fall in the Sensex. The scrip had underperformed the market in past one quarter, falling 0.57% as against Sensex's 4.12% rise. The scrip had outperformed the market in past one year, rising 16.85% as against Sensex's 20.98% rise.

The large-cap company has equity capital of Rs 42.06 crore. Face value per share is Rs 10.

GSK Consumer Healthcare is the category leader in Indian health food drinks industry.

Powered by Capital Market - Live News